These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 28264049)

  • 1. Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.
    Fokkens BT; Mulder DJ; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
    PLoS One; 2017; 12(3):e0173379. PubMed ID: 28264049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface Area of Detachment, Proliferative Vitreoretinopathy, and Pulse Pressure, but not AGEs, are Associated With Retinal Redetachment.
    Fokkens BT; Mulder DJ; Nugteren MB; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6633-6638. PubMed ID: 27926755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relations of advanced glycation endproducts and dicarbonyls with endothelial dysfunction and low-grade inflammation in individuals with end-stage renal disease in the transition to renal replacement therapy: A cross-sectional observational study.
    Martens RJH; Broers NJH; Canaud B; Christiaans MHL; Cornelis T; Gauly A; Hermans MMH; Konings CJAM; van der Sande FM; Scheijen JLJM; Stifft F; Wirtz JJJM; Kooman JP; Schalkwijk CG
    PLoS One; 2019; 14(8):e0221058. PubMed ID: 31408493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
    Hammes HP; Brownlee M; Lin J; Schleicher E; Bretzel RG
    Diabetologia; 1999 May; 42(5):603-7. PubMed ID: 10333054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FACTORS ASSOCIATED WITH PENTOSIDINE ACCUMULATION IN THE HUMAN VITREOUS.
    van Deemter M; Bank RA; Vehof J; Hooymans JM; Los LI
    Retina; 2017 Apr; 37(4):770-777. PubMed ID: 27465571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.
    Choudhuri S; Dutta D; Sen A; Chowdhury IH; Mitra B; Mondal LK; Saha A; Bhadhuri G; Bhattacharya B
    Mol Vis; 2013; 19():100-13. PubMed ID: 23378723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
    Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
    Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies.
    Hanssen NM; Engelen L; Ferreira I; Scheijen JL; Huijberts MS; van Greevenbroek MM; van der Kallen CJ; Dekker JM; Nijpels G; Stehouwer CD; Schalkwijk CG
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1369-73. PubMed ID: 23780372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between glycoxidation and cytokines in the vitreous of eyes with diabetic retinopathy.
    Matsumoto Y; Takahashi M; Ogata M
    Jpn J Ophthalmol; 2002; 46(4):406-12. PubMed ID: 12225819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of mature cross-links and advanced glycation end product cross-links in human vitreous.
    Matsumoto Y; Takahashi M; Chikuda M; Arai K
    Jpn J Ophthalmol; 2002; 46(5):510-7. PubMed ID: 12457909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased nitric oxide (NO) pathway metabolites in the vitreous fluid of patients with rhegmatogenous retinal detachment or diabetic traction retinal detachment.
    Diederen RM; La Heij EC; Deutz NE; Kessels AG; van Eijk HM; Hendrikse F
    Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):683-8. PubMed ID: 16267670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes.
    Osawa S; Katakami N; Sato I; Ninomiya H; Omori K; Yamamoto Y; Takahara M; Miyashita K; Sakamoto F; Kawamori D; Matsuoka T; Shimomura I
    J Diabetes Complications; 2018 Sep; 32(9):839-844. PubMed ID: 30099985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between advanced glycation end products and ocular circulation in type 2 diabetes.
    Hashimoto K; Kunikata H; Yasuda M; Ito A; Aizawa N; Sawada S; Kondo K; Satake C; Takano Y; Nishiguchi KM; Katagiri H; Nakazawa T
    J Diabetes Complications; 2016; 30(7):1371-7. PubMed ID: 27209548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dietary glycemic load is associated with higher concentrations of urinary advanced glycation endproducts: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) Study.
    Maasen K; van Greevenbroek MMJ; Scheijen JLJM; van der Kallen CJH; Stehouwer CDA; Schalkwijk CG
    Am J Clin Nutr; 2019 Aug; 110(2):358-366. PubMed ID: 31240298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment.
    Ogata N; Tombran-Tink J; Nishikawa M; Nishimura T; Mitsuma Y; Sakamoto T; Matsumura M
    Am J Ophthalmol; 2001 Sep; 132(3):378-82. PubMed ID: 11530051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated vitreous nitric oxide levels in patients with proliferative diabetic retinopathy.
    Yilmaz G; Esser P; Kociok N; Aydin P; Heimann K
    Am J Ophthalmol; 2000 Jul; 130(1):87-90. PubMed ID: 11004264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy.
    Nakamura N; Hasegawa G; Obayashi H; Yamazaki M; Ogata M; Nakano K; Yoshikawa T; Watanabe A; Kinoshita S; Fujinami A; Ohta M; Imamura Y; Ikeda T
    Diabetes Res Clin Pract; 2003 Aug; 61(2):93-101. PubMed ID: 12951277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
    Ghanem AA; Elewa A; Arafa LF
    Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.